Delivery Order SPE2DB22D9353-SPE2DB24FX1MS

Award Date 11/16/23
Potential Completion Date 11/17/23
Potential Value $37K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand, six hundred thirty-seven dollars and fifty-two cents ($36,637.52) by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to five million...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand, six hundred thirty-seven dollars and fifty-two cents ($36,637.52) by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was awarded on November 14, 2023 and is to be completed by November 15, 2023. DMS Pharmaceutical Group Inc. will fulfill this order as a prime contractor under an existing indefinite delivery contract with the Defense...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred eighty-three thousand one hundred eighty-seven dollars and sixty cents ($183,187.60) by the Defense Logistics Agency to supply TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand six hundred forty-seven dollars and four cents ($36,647.04) by the Defense Logistics Agency to provide TRIKAFTA 50-25-37.5 MG/75 MG UU 84S. The delivery order was issued on September 22, 2023 with a completion date of September 25, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies. The...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at forty-three thousand nine hundred ninety-four dollars and seventy-six cents ($43,994.76) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to five million dollars through December 2025....
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,328.29 by the Defense Logistics Agency Troop Support Medical to provide TRIKAFTA 50-25-37.5 MG/75 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under the contract, DMS Pharmaceutical Group supplies pharmaceutical items and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-three thousand two hundred ninety-four dollars and twelve cents ($73,294.12) by the Defense Logistics Agency to supply TRIKAFTA 50-25-37.5 MG/75 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred forty-six thousand five hundred fifty dollars and eight cents ($146,550.08) by the Defense Logistics Agency. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,318.75 by the Defense Logistics Agency to provide TRIKAFTA 100-50-75 MG/150 MG UU 84S. The order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will deliver the specified...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $36,637.52 by the Defense Logistics Agency Troop Support Medical to provide TRIKAFTA 100-50-75 MG/150 MG UU 84S. The delivery order was issued on December 6, 2023 under the company's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical wholesaler, DMS Pharmaceutical Group...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB24FX1MS
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-six thousand six hundred fifty-six dollars and sixty cents ($36,656.60) by the Defense Logistics Agency to supply TRIKAFTA 50-25-37.5 MG/75 MG UU 84S. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a leading pharmaceutical wholesaler, DMS Pharmaceutical Group will fulfill the routine needs of military treatment centers supported by the Defense Logistics Agency through delivery of the specified medication by the completion date of November 17, 2023.

Generated 2/15/24, 9:37 AM